Real Protection.
Proven by Data.
Welcome to the lead-free zone.
Rampart is redefining interventional radiation safety with clinical data – not assumptions.
Our peer-reviewed and real-world evidence shows unmatched protection, comfort, and impact across the procedure room.
2 Randomized Controlled Trials
Proven and trusted results with rigorous clinical data.
2 Randomized Controlled Trials
Proven and trusted results with rigorous clinical data.
99% Scatter Radiation Reduction
Backed by clinical trials across multiple roles and room positions.
99% Scatter Radiation Reduction
Backed by clinical trials across multiple roles and room positions.
20x More Effective Than Lead Aprons & Traditional Shields
Outperforms traditional shielding and enables providers to Shed the Lead®.
20x More Effective Than Lead Aprons & Traditional Shields
Outperforms traditional shielding and enables providers to Shed the Lead®.
0 lbs of Wearable Burden
Eliminate spine and joint strain while maximizing procedural freedom.
0 lbs of Wearable Burden
Eliminate spine and joint strain while maximizing procedural freedom.
1,700+ Real-World Reductions
Trusted in cath labs, EP , IR, and hybrid ORs nationwide.
1,700+ Real-World Reductions
Trusted in cath labs, EP , IR, and hybrid ORs nationwide.
Tested, Trusted, & Scientifically Validated
Industry-leading body of evidence with two randomized controlled trials.
Trial of a Novel Radiation Shielding Device to Protect Staff in the Cardiac Catheter Laboratory
- Study Design: Randomized trial of 100 cardiac angiography/intervention cases comparing Rampart Defender to traditional shielding.
- Key Data: Operator radiation exposure reduced by up to 100% across multiple body locations.
- Key Data: Scrub nurse doses also significantly reduced, with some measurements at 0 µSv (0 mRem).
- Claim: No compromise in procedural access or workflow.
Radiation Exposure Using Rampart vs Standard Lead Aprons and Shields During Invasive Cardiovascular Procedures
- Study Design: Randomized trial of 100 elective invasive cardiovascular procedures comparing Rampart Defender with traditional lead aprons and shields (LAS).
- Key Data: Significantly reduced total body radiation exposure for all team members at every measured position.
- Key Data: Head and neck radiation exposure also significantly lower with Rampart.
- Claim: Enabled lead-free procedures without increasing fluoroscopy time or compromising procedural performance.
Systematic Comparison of the Efficacy of Various Radiation Protection Devices in Reducing Operator Scatter Radiation Dose in the Cardiac Catheterization Laboratory
- Study Design: Comparing four shielding setups, including Rampart IC, for scatter dose reduction in the cath lab.
- Key Data: Rampart IC with table skirt achieved the greatest dose reduction—averaging 95% less radiation vs. no shielding.
- Key Data: Outperformed other tested devices (STARTable, EggNest, usual shielding) across multiple projection angles.
- Claim: Provides high-level radiation protection without the burden of heavy lead aprons.
Rampart Radiation Scatter Report
- Study Design: Lab-based study measuring scatter radiation during simulated cardiac procedures with and without Rampart Defender and Bunker systems.
- Key Data: Rampart Defender with full configuration reduced scatter radiation by up to 99% compared to no shielding.
- Key Data: Across all measurement points, Rampart devices consistently outperformed baseline and partial shielding setups, with >90% reduction in most scenarios.
- Claim: Rampart shielding systems provide substantial scatter radiation protection for operators, significantly exceeding the reduction achieved by standard shielding methods.
Comparison of Effective Radiation Shielding Between a Portable, Configurable, Floor-Supported Radiation System vs Conventional Apron and Shields in Clinical Interventional Procedures: Quality of Life Sub-Study
- Study Design: Two-part study evaluating Rampart Defender vs. traditional lead aprons for both quality of life and radiation exposure in the cath lab.
- Key Data: Daily and weekly surveys showed lead aprons increased odds of pain by up to 19.8× and fatigue by 25.9× vs. Rampart.
- Key Data: Radiation monitoring in 63 procedures found significantly lower exposure at the temple and arm/shoulder with Rampart (alone or combined with lead) compared to lead alone.
- Claim: Results suggest Rampart improves comfort, reduces orthopedic strain, and provides effective radiation protection without compromising safety.
Radiation Exposure During Invasive Cardiovascular Procedures: Portable Shielding System Versus Standard Lead Aprons
- Study Design: Prospective, single-center study of 100 elective cardiac procedures comparing standard lead apron protection vs. Rampart Defender portable shielding.
- Key Data: Neck-level radiation dose to operators averaged 0.5 µSv with Rampart vs. 12.9 µSv with lead (p < 0.0001)
- Key Data: Rampart group had significantly lower neck-level radiation vs. non-Rampart: operator 0.5 vs 1.5 µSv, assistant 1.5 vs 3.6 µSv, radiographer 0.6 vs 1.3 µSv (p ≤ 0.002).
- Claim: Rampart Defender reduced neck-level radiation exposure across the cath lab team without impeding workflow, potentially lowering long-term health risks from scatter radiation.
Orthopedic Risks to Cardiac Catheterization Operators Wearing Traditional Lead Protection Versus Using Novel Lead-Less Solutions: Insights from the Prospective ERGO-CATH Study
- Study Design: Single-center prospective study using IMUs to quantify ergonomic strain on cath lab operators’ cervical, thoracic, torso-pelvic, and lumbar regions.
- Key Data: Operators spent up to 36% of case time in high-risk cervical rotation, 16% in cervical flexion, and 6% in thoracic flexion, with higher discomfort wearing lead vs lead-less (23% vs 12%).
- Claim: Rampart reduced operator discomfort in women to under 10%, compared to 50% reporting discomfort when wearing lead aprons.
Real-World Reductions in Lead-Free Radiation Exposure with the Rampart System during Endovascular Procedures
- Study Design: Prospective, multicenter study of 1,712 endovascular procedures by 671 operators at 153 sites using the Rampart M1128 lead-free shielding system.
- Key Data: System combined interlocking bismuth acrylic panels (1.0 mm lead equivalent) with soft shielding (0.5 mm lead equivalent).
- Key Data: Live dosimeters at the operator shoulder showed median exposure of 2 μSv (.2 mRem) for main operators and 1 μSv (.1 mRem) for assistants.
- Claim: Results show Rampart enables safe, lead-free procedures with effective radiation protection.
TESTIMONIALS/RAMPART MINUTE
Brittney Meckley, BS, RCIS
Manager of Invasive Cardiology
WellSpan Gettysburg Hospital,
Gettysburg, PA
Jamie Rosier, RCIS
Interventional Cardiovascular
Technologist Lead
WellSpan York Hospital, York, PA
Laurisa Varela, RCIS
Interventional Cardiovascular
Technologist Lead
WellSpan York Hospital, York, PA
John T. Eagan, MD
Interventional Cardiologist
Baptist Health Brookwood Hospital
“Rampart should be the standard of care – protecting operators from radiation and eliminating orthopedic risk.”
William “Bill” Lombardi, MD
Interventional Cardiologist
UW Medical Center – Montlake
“Not only did I want to make it to where I didn’t have to wear lead, but also so my staff didn’t have to.”
Mustafa Ahmed, MD
Interventional Cardiologist
UAB Medicine
“I had almost forgotten what it was like to not wear lead every day. Rampart is life changing. I feel more protected!”